Literature DB >> 14718000

Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection.

R K Alwadhi1, J L Mathew, B Rath.   

Abstract

OBJECTIVE: This is a prospective, hospital based study over a period of one year, to examine the clinical profile of nephrotic children not on glucocorticoid therapy, but presenting with infection.
METHODS: Sixty-eight children with 76 episodes of nephrotic syndrome were enrolled during the study year. They were examined for evidence of infection using clinical and investigative criteria. The children were monitored daily for proteinuria and improvement of infection. After the infection was controlled, prednisolone therapy was started in those who were not already in remission.
RESULTS: Of the 76 episodes, eight were excluded from analysis as they had developed infection while they were on glucocorticoid therapy. Of the remaining 68 nephrotic episodes in 60 children, there was evidence of infection in 57 episodes (83.8%). Upper respiratory infection was the most common (28.0%) followed by urinary tract infection (22.8%), peritonitis (15.8%), pneumonia (14.0%), acute invasive diarrhoea (10.5%) and empyema (5.3%). Children with infection had significantly lower serum albumin and higher serum cholesterol compared to non-infected children. Of the 57 episodes with infection, remission occurred with control of infection alone in nine episodes (15.8%) and glucocorticoid therapy was not required.
CONCLUSION: Infection is widely prevalent among Indian children presenting with episodes of nephrotic syndrome, even when they are not on glucocorticoid therapy. Some children may go into remission by control of infection alone. Among the infections, upper respiratory and urinary tract infections are the most common.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718000     DOI: 10.1111/j.1440-1754.2004.00285.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  24 in total

1.  Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome.

Authors:  Michelle N Rheault; Chang-Ching Wei; David S Hains; Wei Wang; Bryce A Kerlin; William E Smoyer
Journal:  Pediatr Nephrol       Date:  2013-09-14       Impact factor: 3.714

2.  Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy.

Authors:  Yoshitsugu Kaku; Yasufumi Ohtsuka; Yasuhiro Komatsu; Toshiyuki Ohta; Takuhito Nagai; Hiroshi Kaito; Shuji Kondo; Yohei Ikezumi; Seiji Tanaka; Shinsuke Matsumoto; Mayumi Sako; Kazushi Tsuruga; Koichi Nakanishi; Koichi Kamei; Hiroshi Saito; Shuichiro Fujinaga; Yuko Hamasaki; Hiroko Chikamoto; Kenji Ishikura; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2015-02       Impact factor: 2.801

Review 3.  Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.

Authors:  Kazunari Kaneko; Shoji Tsuji; Takahisa Kimata; Tetsuya Kitao; Sohsaku Yamanouchi; Shogo Kato
Journal:  World J Pediatr       Date:  2015-01-28       Impact factor: 2.764

4.  Minimal change disease: a "two-hit" podocyte immune disorder?

Authors:  Michiko Shimada; Carlos Araya; Chris Rivard; Takuji Ishimoto; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2010-10-30       Impact factor: 3.714

5.  Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis.

Authors:  Nafsika Afentou; Emma Frew; Samir Mehta; Natalie J Ives; Rebecca L Woolley; Elizabeth A Brettell; Adam R Khan; David V Milford; Detlef Bockenhauer; Moin A Saleem; Angela S Hall; Ania Koziell; Heather Maxwell; Shivaram Hegde; Eric Finlay; Rodney D Gilbert; Caroline Jones; Karl McKeever; Wendy Cook; Nicholas J A Webb; Martin T Christian
Journal:  Pharmacoecon Open       Date:  2022-06-22

6.  T cell CD3 receptor zeta (TCRzeta)-chain expression in children with idiopathic nephrotic syndrome.

Authors:  Diego H Aviles; Matti V Vehaskari; Kirk S Culotta; Jennifer Manning; Augusto C Ochoa; Arnold H Zea
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

7.  Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?

Authors:  Gabriel Cara-Fuentes; Clive H Wasserfall; Heiman Wang; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2014-07-14       Impact factor: 3.714

8.  Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study.

Authors:  Nermin Uncu; Mehmet Bülbül; Nurdan Yildiz; Aytul Noyan; Cemlettin Koşan; Salih Kavukçu; Salim Calişkan; Zübeyde Gündüz; Nesrin Beşbaş; Ayfer Gür Güven
Journal:  Eur J Pediatr       Date:  2009-05-09       Impact factor: 3.183

Review 9.  Podocytopathies.

Authors:  Jeffrey B Kopp; Hans-Joachim Anders; Katalin Susztak; Manuel A Podestà; Giuseppe Remuzzi; Friedhelm Hildebrandt; Paola Romagnani
Journal:  Nat Rev Dis Primers       Date:  2020-08-13       Impact factor: 52.329

10.  Astragalus in the prevention of upper respiratory tract infection in children with nephrotic syndrome: evidence-based clinical practice.

Authors:  Chuan Zou; Guobin Su; Yuchi Wu; Fuhua Lu; Wei Mao; Xusheng Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-09       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.